The warning label placed on all estrogen-based treatments since 2003 was based on an outdated and flawed government-funded study.

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

When going through perimenopause and menopause, you’ll likely experience hot flashes, mood swings and other symptoms. This is because your body is changing and your hormone levels are fluctuating. To ...

NATIONAL HARBOR, Maryland — Anywhere from 1 million to 2.5 million women in the United States — about 2% of the female population older than 40 years — are using "bioidentical" compounded menopausal ...

The menopause transition is an innate part of aging for women. Menopause is marked by the end of menstruation and a myriad of physical and emotional symptoms, including hot flashes, migraines, ...

What began as a single clinic in Colorado has evolved into a well-regarded provider of hormone optimization and replacement care, now serving more than 10,000 patients.

Navigating the complexities of hormonal changes throughout life can be a daunting task for both women and men. From puberty to mature adulthood, these milestones present unique challenges that require ...

Misinformation around menopause is still frustratingly common—among both doctors and patients. We asked experts why you shouldn't believe these five myths. While nearly half the world will contend ...

"Seated woman with bent knee" by Austrian artist Egon Schiele, 1917. Source: Photo credit: Bridgeman Images. Used with permission. During the transition to menopause and even well beyond menopause for ...

Women will spend approximately one-third of their lives after the menopause transition and approximately 6,000 women reach menopause every day in the United States. While menopause is a natural ...

The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity and instead ...

In recent years, an increasing number of health care providers and patients have turned to compounded drugs for the treatment of hormone-related health concerns. These products are often marketed as ...